keyboard_arrow_up

Global Hepatitis D Clinical Trials Market Review H2 2014

“Hepatitis D Global Clinical Trials Review, H2, 2014″ provides data on the Hepatitis D clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatitis D. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatitis D. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

List of Tables

Hepatitis D Therapeutics, Global, Clinical Trials by Region, 2014* 6

Hepatitis D Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7

Hepatitis D Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8

Hepatitis D Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9

Hepatitis D Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10

Hepatitis D Therapeutics Clinical Trials, North America, Top Countries, 2014* 11

Hepatitis D Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 12

Proportion of Hepatitis D to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 13

Hepatitis D Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14

Hepatitis D Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15

Proportion of Hepatitis D to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 16

Hepatitis D Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17

Hepatitis D Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18

Hepatitis D Therapeutics, Global, Clinical Trials by Phase, 2014* 19

Hepatitis D Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20

Hepatitis D Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21

Hepatitis D Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22

Hepatitis D Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23

Hepatitis D Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24

Hepatitis D Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25

Hepatitis D Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26

Hepatitis D Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27

Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 29

Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by Eiger BioPharmaceuticals, Inc., 2014* 30

Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by REPLICor Inc., 2014* 31

Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by MYR GmbH, 2014* 32

Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 33

Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by Hepatera LLC, 2014* 34

Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014* 35

Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2014* 36

Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by German Liver Foundation, 2014* 37

Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 38

To get Discount on this report, visit: http://www.rnrmarketresearch.com/contacts/discount?rname=256167 .

This is a premium report priced at US$2500 for a single user PDF.

Scope

·         Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

·         Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

·         Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

·         Understand the dynamics of a particular indication in a condensed manner

·         Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

·         Obtain discontinued trial listing for trials across the globe

·         Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies